Infections in 252 patients with common variable immunodeficiency.
暂无分享,去创建一个
É. Oksenhendler | P. Debré | R. Jaussaud | E. Hachulla | J. Viallard | L. Galicier | N. Schleinitz | F. Suarez | C. Fieschi | A. Jaccard | C. Rabian | P. Soulas-Sprauel | L. Gérard | M. Malphettes | M. Gardembas | Anaelle Gardeur | I. Theodorou | Gaël Mouillot | Pauline Soulas-Sprauel
[1] A. Plebani,et al. Long-Term Follow-Up and Outcome of a Large Cohort of Patients with Common Variable Immunodeficiency , 2007, Journal of Clinical Immunology.
[2] A. Sauvanet,et al. Infection after cyanoacrylate injection: a fatal complication in a patient with portal hypertension associated with common variable immunodeficiency. , 2007, Endoscopy.
[3] A. Durandy,et al. Memory switched B cell percentage and not serum immunoglobulin concentration is associated with clinical complications in children and adults with specific antibody deficiency and common variable immunodeficiency. , 2006, Clinical immunology.
[4] A. Smail,et al. Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency , 2006, American journal of hematology.
[5] M. van der Burg,et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. , 2006, The New England journal of medicine.
[6] N. Rezaei,et al. Effect of regular intravenous immunoglobulin therapy on prevention of pneumonia in patients with common variable immunodeficiency. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[7] C. Cunningham-Rundles,et al. Treatment and outcome of autoimmune hematologic disease in common variable immunodeficiency (CVID). , 2005, Journal of autoimmunity.
[8] R. Geha,et al. TACI is mutant in common variable immunodeficiency and IgA deficiency , 2005, Nature Genetics.
[9] A. Schäffer,et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans , 2005, Nature Genetics.
[10] A. Kokuludağ,et al. Common variable immunodeficiency (CVID) presenting with malabsorption due to giardiasis. , 2005, The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology.
[11] A. Plebani,et al. ICOS deficiency in patients with common variable immunodeficiency. , 2004, Clinical immunology.
[12] H. Lyall,et al. Recurrent meningitis in association with common variable immune deficiency. , 2004, Indian pediatrics.
[13] É. Oksenhendler,et al. Autoimmune Thrombocytopenic Purpura and Common Variable Immunodeficiency: Analysis of 21 Cases and Review of the Literature , 2004, Medicine.
[14] E. Pallisa,et al. Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency. , 2004, International immunopharmacology.
[15] A. Schäffer,et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency , 2003, Nature Immunology.
[16] H. Chapel,et al. European surveillance of immunoglobulin safety--results of initial survey of 1243 patients with primary immunodeficiencies in 16 countries. , 2002, Clinical immunology.
[17] C. Cunningham-Rundles,et al. Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. , 2002, The Journal of allergy and clinical immunology.
[18] A. Denz,et al. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. , 2002, Blood.
[19] C. Kallenberg,et al. The Effect of Two Different Dosages of Intravenous Immunoglobulin on the Incidence of Recurrent Infections in Patients with Primary Hypogammaglobulinemia , 2001, Annals of Internal Medicine.
[20] I. Vořechovský,et al. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID) , 2000, Clinical and experimental immunology.
[21] L. Notarangelo,et al. Diagnostic Criteria for Primary Immunodeficiencies , 1999 .
[22] C. Cunningham-Rundles,et al. Common variable immunodeficiency: clinical and immunological features of 248 patients. , 1999, Clinical immunology.
[23] A. Fischer,et al. Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinemia: a retrospective survey of 31 patients. , 1999, The Journal of pediatrics.
[24] J. Björkander,et al. 1040 Prophylactic infusions with an unmodified intravenous immunoglobulin product causing few side-effects in patients with antibody deficiency syndromes , 1985, Infection.
[25] Eren,et al. The EUROclass trial: defining subgroups in common variable immunodeficiency. , 2008, Blood.
[26] B. Piqueras,et al. Common Variable Immunodeficiency Patient Classification Based on Impaired B Cell Memory Differentiation Correlates with Clinical Aspects , 2003, Journal of Clinical Immunology.
[27] C. Kallenberg,et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. , 2001, Annals of internal medicine.
[28] L. Notarangelo,et al. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). , 1999, Clinical immunology.
[29] R. Hermaszewski,et al. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. , 1993, The Quarterly journal of medicine.